Matt Gregory
7Patents
0h-index
4Co-inventors
24Inventor score
Filing activity: Jan 19, 2018 → Feb 22, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11059845B2 | Immune stimulating macrolides | Human Necessities | 0 | Active |
| US11059846B2 | Immune stimulating compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US11304990B2 | Use of known compounds—intracellular infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US11564969B2 | Immunorhelin compounds for intracellular infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US11059844B2 | Immune stimulating macrolides | Human Necessities | 0 | Active |
| US10919927B2 | Immune stimulating macrolide | Emerging Cross-Sectional Technologies | 0 | Active |
| US11434258B2 | Compounds (immunorhelins) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.